A phase I QTc study of tivozanib in patients with advanced solid tumors. Background: Renal cell ca (RCC) is one of solid tumor with relatively highest incidence of venous thromboembolism (VTE). But, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results